# Drug Interaction Study Between AZD3480 and Cytochrome P450

> **NCT00692510** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 18 (estimated)

## Conditions studied

- Metabolism
- Alzheimer's Disease

## Interventions

- **DRUG:** AZD3480
- **DRUG:** Placebo
- **DRUG:** Cocktail mix (Caffeine, Bupropion, Rosiglitazone, Omeprazole, Midazolam, Bilirubin)

## Key facts

- **NCT ID:** NCT00692510
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2008-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00692510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00692510, "Drug Interaction Study Between AZD3480 and Cytochrome P450". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00692510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*